Product
RSO-021
Aliases
Thiostrepton
1 clinical trial
5 indications
Indication
Malignant Pleural EffusionIndication
MesotheliomaIndication
Mesothelioma, Malignant, PleuralIndication
pleural effusionIndication
malignantClinical trial
A Translational Phase 1/2 Dose-Escalation and Expansion Study to Determine Safety, Tolerability, and Recommended Phase 2 Dose of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including MesotheliomaStatus: Recruiting, Estimated PCD: 2025-04-01